Though no official court decisions or awards have been granted at this time, the FDA has recently added severe risk of intestinal damage to Ozempics warning label, and cases are underway in both the US and Canada.
this is of particular concern in older adults or those taking diuretics or medicines acting on the reninangiotensinaldosterone system (RAAS) Of greater concern for long-term use are potential risks identified with related drug classes : Thyroid C-cell tumours : Studies in rodents have shown C-cell tumours with GLP-1 receptor agonists
Understanding the physiological reasons behind this, from water retention to metabolic adaptation, is essential before drawing any conclusions about whether your calorie deficit is working
However, it is important to emphasise that whilst the biological plausibility exists, there is no official link established between GLP-1 receptor agonists and ADHD treatment
Boost your weight loss journey with our Fitty GLP-1 Daily capsule + Fitty ACV fizz duo
A 2025 meta-analysis published in Endocrinology, Diabetes & Metabolism, pooling data from four studies with nearly 29,000 patients, confirmed a consistent advantage for tirzepatide, with an average additional weight reduction of 4.84 kg compared to semaglutide